š”š²šš š¦ššŗšŗš®šæš
ā¢ Strides Pharma reported a 11.41% increase in net sales in September 2023 compared to the same period in 2022.
ā¢ The company also saw a significant decrease in net loss, down 675.43% from the previous year.
ā¢ EBITDA also showed a strong growth of 55.42% in September 2023 compared to the same period in 2022.